Mitsubishi UFJ Trust & Banking’s Xeris Biopharma Holdings XERS Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$166K	Buy	+20,925	New	+$134K	﹤0.01%	1378

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

LCM

Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's XERS Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 20,925 shares worth $166K. The stake represents ﹤0.01% of the portfolio and ranks #1378 among its holdings.

78 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 20,925 shares of Xeris Biopharma Holdings worth $166K as of Q2 2026.
Xeris Biopharma Holdings was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
Xeris Biopharma Holdings made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1378 holding.
78 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.